Every organization has its proprietary resources: compounds, data, knowledge and know-how. At the early stage of drug discovery, pooling these resources can yield results that surpass what organizations could otherwise achieve. Stakeholders in pharmaceutical research need each other - and their proprietary resources - to take their work and achievements to the next levels.

TI Pharma targets priority medicine research by facilitating and safeguarding the flow of competitive information between partners. Guided by TI Pharma's expertise, resources can be effectively and safely shared.

TI Pharma facilitates several such partnerships, including:

  • The European Lead Factory: Pan-European, 30-partner consortium to connect compound libraries and encourage new discoveries
  • Kinetics for Drug Discovery: Pan-European, 20-partner consortium to solve efficacy issues in drug candidate development, based on a novel concept called "target residence time"

“TI Pharma's program managers are experts in the content, enabling them to keep parties focused on the goals that were agreed upon at the outset.”

Jan Raaijmakers
Past VP External Scientific Collaborations GSK Europe
Chair TI Pharma Board of Directors

Share this page: